Joshua Henshaw

发表

Field distribution and DNA transport in solid tumors during electric field-mediated gene delivery.

F. Yuan, Joshua Henshaw, 2008, Journal of pharmaceutical sciences.

Electric field-mediated transport of plasmid DNA in tumor interstitium in vivo.

F. Yuan, Joshua Henshaw, D. Zaharoff, 2007, Bioelectrochemistry.

Lack of germline transmission in male mice following a single intravenous administration of AAV5-hFVIII-SQ gene therapy

Joshua Henshaw, C. O’Neill, C. Fonck, 2022, Gene Therapy.

Telaprevir in combination with peginterferon Alfa-2a/ribavirin in HCV/HIV co-infected patients: SVR12 interim analysis

V. Soriano, D. Dieterich, Joshua Henshaw, 2012 .

Combination Therapy With Telaprevir for Chronic Hepatitis C Virus Genotype 1 Infection in Patients With HIV

V. Soriano, D. Dieterich, J. Rockstroh, 2013, Annals of Internal Medicine.

Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis.

J. Cooper, Joshua Henshaw, C. O’Neill, 2015, Molecular genetics and metabolism.

Telaprevir-related dermatitis.

R. Stern, M. Mockenhaupt, J. Roujeau, 2013, JAMA dermatology.

Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration

P. Slasor, T. Ajayi, Joshua Henshaw, 2020, Clinical and translational science.

Clinical and pharmacodynamics of cerliponase alfa, enzyme replacement therapy for CLN2 disease by intracerebroventricular administration

P. Slasor, T. Ajayi, Joshua Henshaw, 2020 .

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.

M. Ozelo, D. Quon, A. Leavitt, 2022, The New England journal of medicine.

Young mice administered adult doses of AAV5-hFVIII-SQ achieve therapeutic factor VIII expression into adulthood

S. Sisó, S. Bunting, S. Fong, 2022, Molecular therapy. Methods & clinical development.

Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria

B. Schweighardt, K. Larimore, B. Burton, 2021, Clinical and translational science.

Abstract C295: Update on first-in-man trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors.

J. Bono, L. Byers, Z. Wainberg, 2013 .

Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transfer

Joshua Henshaw, S. Zoog, Fan Yang, 2021, Gene therapy.

Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia

K. Larimore, M. Irving, J. Hoover-Fong, 2021, Clinical Pharmacokinetics.

Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study.

B. Schweighardt, P. Slasor, T. Ajayi, 2018, Clinical immunology.

Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers.

David C. Smith, N. Curtin, L. Byers, 2017, Cancer discovery.

A Viral Dynamic Model for Treatment Regimens with Direct-acting Antivirals for Chronic Hepatitis C Infection

Varun Garg, Holly Kimko, Bambang S. Adiwijaya, 2012, PLoS Comput. Biol..

Mechanistic Analysis of Electroporation-Induced Cellular Uptake of Macromolecules

F. Yuan, Joshua Henshaw, D. Zaharoff, 2008, Experimental biology and medicine.

First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors

D. Matei, N. Curtin, J. Bono, 2013 .

Safety, pharmacokinetics and CNS distribution of tralesinidase alfa administered via intracerebroventricular infusion to juvenile cynomolgus monkeys

Emma McCullagh, Joshua Henshaw, C. O’Neill, 2023, Toxicology reports.

A single molecule detection method for understanding mechanisms of electric field-mediated interstitial transport of genes.

F. Yuan, Joshua Henshaw, D. Zaharoff, 2006, Bioelectrochemistry.

Dose selection for intracerebroventricular cerliponase alfa in children with CLN2 disease, translation from animal to human in a rare genetic disease

Joshua Henshaw, C. O’Neill, M. Katz, 2021, Clinical and translational science.

Nano-biosensor development for bacterial detection during human kidney infection: Use of glycoconjugate-specific antibody-bound gold NanoWire arrays (GNWA)

Juan Jiang, Subhash Basu, Patrick J. Boyle, 2004, Glycoconjugate Journal.

Enhancement of Electric Field-Mediated Gene Delivery Through Pretreatment of Tumors With a Hyperosmotic Mannitol Solution

F. Yuan, Joshua Henshaw, B. Mossop, 2010, Cancer Gene Therapy.

Relaxin treatment of solid tumors: effects on electric field–mediated gene delivery

F. Yuan, Joshua Henshaw, B. Mossop, 2008, Molecular Cancer Therapeutics.

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.

J. Oldenburg, M. Ozelo, D. Quon, 2023, The New England journal of medicine.

Electric Fields around and within Single Cells during Electroporation—A Model Study

R. Barr, F. Yuan, Joshua Henshaw, 2007, Annals of Biomedical Engineering.

Electric Fields in Tumors Exposed to External Voltage Sources: Implication for Electric Field-Mediated Drug and Gene Delivery

R. Barr, F. Yuan, Joshua Henshaw, 2006, Annals of Biomedical Engineering.

Safety and antitumor activity of the PARP inhibitor BMN673 in a phase 1 trial recruiting metastatic small-cell lung cancer (SCLC) and germline BRCA-mutation carrier cancer patients.

D. Matei, J. Bono, L. Byers, 2014 .